SII’s Adar Poonawalla To Get ‘Y’ Category Security After ‘Threats’
Serum Institute of India’s CEO Adar Poonawalla will get ‘Y’ category security across India by the CRPF, the Union government officials said on Wednesday. The Union government’s decision came after Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII), Prakash Kumar Singh hadwritten to Union Home Minister Amit Shah on April 16 requesting security for Poonawalla.
Covishield, one of the two COVID-19 vaccines used in India’s COVID-19 vaccination programme, is being manufactured by SII. In this letter, Singh had stated that Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies. In this letter, Singh also said, “we are working shoulder to shoulder to fight against COVID-19 pandemic with the Government of India under the dynamic leadership of Prime Minister Narendra Modi Ji.”
ABOUT SII
Serum Institute of India Pvt. Ltd. is now the world’s largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Serum Institute of India is ranked as India’s No. 1 biotechnology company, manufacturing highly specialized life-saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties.
